CelLBxHealth plc
Company Profile
CelLBxHealth plc is a CTC intelligence company specializing in innovative circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology. Its patent-protected Parsortix® platform harvests CTCs from blood and can be integrated with existing laboratory instruments for comprehensive downstream analysis - including whole-cell imaging, proteomic profiling and full genomic workflows.
Investor Access
Peter Collins, Chief Executive Officer, will provide an overview of the Company's preliminary results via the Investor Meet Company platform at 11:00 BST on Monday, 22 June 2026. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 09:00 BST the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet CelLBxHealth plc via: https://www.investormeetcompany.com/cellbxhealth-plc/register
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results | 22 June |
| Interim Results* | September |
| AGM* | June |
* Months based on previous announcements of this kind
